Publication | Open Access
Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma
51
Citations
41
References
2001
Year
This combined regimen has definite activity in MPM. However, toxicity, particularly myelosuppression and fatigue, is not negligible and may limit its application.
| Year | Citations | |
|---|---|---|
Page 1
Page 1